Kymera Therapeutics, Inc. · NASDAQ:KYMR
Kymera Therapeutics, Inc. shareholders
As of Jun 30, 2026, 262 institutions reported holding Kymera Therapeutics, Inc. Largest: T. Rowe Price, Fidelity and Baker Bros. Advisors LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kymera Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 13.4M | +1.84M | Aug 14, 2026 | |
| Fidelity | 12.3M | +649K | Aug 13, 2026 | |
| Baker Bros. Advisors LP | 8.66M | no change | Aug 14, 2026 | |
| Avoro Capital Advisors LLC | 7.47M | no change | Aug 14, 2026 | |
| Vanguard | 6.47M | +194K | Aug 13, 2026 | |
| BlackRock | 5.54M | +477K | Aug 7, 2026 | |
| Bvf Inc | 3.87M | −1.63M | Aug 14, 2026 | |
| Wellington | 3.68M | −215K | Aug 14, 2026 | |
| Siren, L.L.C. | 2.94M | −251K | Aug 13, 2026 | |
| Atlas Venture Life Science Advisors, LLC | 2.85M | −1.73M | Aug 13, 2026 |